BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9614208)

  • 21. Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells.
    Delidow BC; Billis WM; Agarwal P; White BA
    Mol Endocrinol; 1991 Nov; 5(11):1716-22. PubMed ID: 1779973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase-C mediates chicken vasoactive intestinal peptide stimulated prolactin secretion and gene expression in turkey primary pituitary cells.
    Sun S; el Halawani ME
    Gen Comp Endocrinol; 1995 Sep; 99(3):289-97. PubMed ID: 8536940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of age on transforming growth factor-beta 1 inhibition of prolactin gene expression versus secretion in rat anterior pituitary cells.
    Tan SK; Wang FF; Pu HF; Liu TC
    Endocrinology; 1997 Mar; 138(3):878-85. PubMed ID: 9048586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ca2+ and hormones interact synergistically to stimulate rapidly both prolactin production and overall protein synthesis in pituitary tumor cells.
    Brostrom MA; Brostrom CO; Bocckino SB; Green SS
    J Cell Physiol; 1984 Nov; 121(2):391-401. PubMed ID: 6436256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3.
    Lamm ML; Long DD; Goodwin SM; Lee C
    Endocrinology; 1997 Nov; 138(11):4657-64. PubMed ID: 9348191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta 1 is chemotactic for interleukin-2-activated natural killer cells.
    Maghazachi AA; al-Aoukaty A
    Nat Immun; 1993; 12(2):57-65. PubMed ID: 8318816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of PKCepsilon in R6 fibroblasts causes increased production of active TGFbeta.
    Cacace AM; Ueffing M; Han EK; Marmè D; Weinstein IB
    J Cell Physiol; 1998 Jun; 175(3):314-22. PubMed ID: 9572476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta2 regulates C3 secretion in monocytes through a protein kinase C-dependent pathway.
    Drouin SM; Kiley SC; Carlino JA; Barnum SR
    Mol Immunol; 1998 Jan; 35(1):1-11. PubMed ID: 9683259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The co-mitogenic combination of transforming growth factor beta 1 and bombesin protects protein kinase C-delta from late-phase down-regulation, despite synergy in diacylglycerol accumulation.
    Olivier AR; Hansra G; Pettitt TR; Wakelam MJ; Parker PJ
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):519-25. PubMed ID: 8809041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-transforming growth factor-alpha processing in human colon carcinoma cells: role of protein kinase C.
    Ramesh G; Levine AE
    Int J Cancer; 1995 Aug; 62(4):492-7. PubMed ID: 7635577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The involvement of protein kinase C in mediating growth suppressive signals of interferons in hematopoietic cells.
    Tiefenbrun N; Kimchi A
    Oncogene; 1991 Jun; 6(6):1001-7. PubMed ID: 1712443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta2-mediated regulation of C3 gene expression in monocytes.
    Drouin SM; Carlino JA; Barnum SR
    Mol Immunol; 1996 Sep; 33(13):1025-34. PubMed ID: 9010241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of transforming growth factor alpha during differentiation of human pancreatic cancer cells.
    Estival A; Clerc P; Vaysse N; Tam JP; Clemente F
    Gastroenterology; 1992 Dec; 103(6):1851-9. PubMed ID: 1451978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C alpha, epsilon and AP-1 mediate prolactin regulation of mitochondrial aspartate aminotransferase expression in the rat lateral prostate.
    Franklin RB; Zou J; Ma J; Costello LC
    Mol Cell Endocrinol; 2000 Dec; 170(1-2):153-61. PubMed ID: 11162899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional and posttranscriptional regulation of the rat prolactin gene by calcium.
    Preston GM; Billis WM; White BA
    Mol Cell Biol; 1990 Feb; 10(2):442-8. PubMed ID: 2300047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intracellular calcium antagonist, TMB-8, inhibits prolactin gene expression in GH3 cells.
    Preston GM; White BA
    Life Sci; 1987 Nov; 41(20):2289-94. PubMed ID: 3683076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of protein kinase C activity by modulating factors and Euonymus alatus (Thunb.) Sieb in human myometrial and uterine leiomyomal smooth muscle cells.
    Lee TK; Lee JY; Kim DI; Lee YC; Kim CH
    Int J Gynecol Cancer; 2005; 15(2):349-58. PubMed ID: 15823124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin as a hepatotrophic hormone.
    Buckley AR; Russell DH; Montgomery DW; Putnam CW
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):706-9. PubMed ID: 3347958
    [No Abstract]   [Full Text] [Related]  

  • 39. UVC activation of the HeLa cell membrane "TGF alpha ase," a metalloenzyme.
    Piva TJ; Krause DR; Ellem KO
    J Cell Biochem; 1997 Mar; 64(3):353-68. PubMed ID: 9057093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion.
    Ouhtit A; Madani S; Gupta I; Shanmuganathan S; Abdraboh ME; Al-Riyami H; Al-Farsi YM; Raj MH
    J Cancer; 2013; 4(7):566-72. PubMed ID: 23983821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.